Paralytic syndrome, unspecified
ICD-10 G83.9 is a billable code used to indicate a diagnosis of paralytic syndrome, unspecified.
Paralytic syndrome, unspecified (G83.9) refers to a condition characterized by a loss of voluntary muscle function due to damage to the nervous system. This syndrome can manifest in various forms, including cerebral palsy, paralysis, paraplegia, and quadriplegia. Cerebral palsy is a group of disorders affecting movement and muscle tone, often resulting from brain injury during development. Paralysis can be complete or partial and may affect one or more limbs, leading to mobility impairments. Paraplegia specifically refers to paralysis of the lower limbs, while quadriplegia involves paralysis of all four limbs. Patients may experience varying degrees of mobility impairment, which can significantly impact their daily activities and quality of life. The unspecified nature of this code indicates that the specific type of paralysis or underlying cause has not been clearly defined, necessitating further clinical evaluation and documentation to determine the precise nature of the condition.
Detailed neurological examination findings, including motor function assessments and diagnostic imaging results.
Patients presenting with sudden onset of paralysis, chronic conditions leading to mobility impairments, or post-stroke rehabilitation.
Ensure that all neurological assessments are documented to support the diagnosis and any associated treatments.
Comprehensive rehabilitation plans, including functional assessments and progress notes.
Patients undergoing rehabilitation for mobility impairments due to paralysis or neurological conditions.
Documenting the patient's functional status and response to therapy is crucial for accurate coding and billing.
Used for patients undergoing rehabilitation for mobility impairments due to paralysis.
Documentation of the patient's functional status and progress in therapy.
Physical therapy notes should clearly link the exercises to the diagnosis of paralysis.
G83.9 should be used when the specific type of paralytic syndrome is not documented or when the clinician has not specified the underlying cause of paralysis.
